azoxymethane has been researched along with Local Neoplasm Recurrence in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (50.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bagni, C; Di Fusco, D; Di Grazia, A; Dinallo, V; Franzè, E; Laudisi, F; Marafini, I; Monteleone, G; Monteleone, I; Pedini, G; Rosina, E; Sica, G; Sileri, P; Stolfi, C | 1 |
| Ballet, F; Delelo, R; Herve, JP; Nordlinger, B; Panis, Y; Puts, JP | 1 |
2 other study(ies) available for azoxymethane and Local Neoplasm Recurrence
| Article | Year |
|---|---|
The Fragile X Mental Retardation Protein Regulates RIPK1 and Colorectal Cancer Resistance to Necroptosis.
Topics: Animals; Azoxymethane; Carcinogenesis; Case-Control Studies; Cell Culture Techniques; Cell Line, Tumor; Colon; Colorectal Neoplasms; Datasets as Topic; Disease-Free Survival; Fragile X Mental Retardation Protein; Gene Expression Regulation, Neoplastic; Gene Knockdown Techniques; Healthy Volunteers; Humans; Male; Mice; Mice, Knockout; Necroptosis; Neoplasm Recurrence, Local; Neoplasms, Experimental; Organoids; Prognosis; Receptor-Interacting Protein Serine-Threonine Kinases | 2021 |
Experimental model of colon cancer: recurrences after surgery alone or associated with intraperitoneal 5-fluorouracil chemotherapy.
Topics: Adenocarcinoma; Animals; Azoxymethane; Colectomy; Colonic Neoplasms; Combined Modality Therapy; Disease Models, Animal; Fluorouracil; Injections, Intraperitoneal; Liver Neoplasms; Male; Neoplasm Recurrence, Local; Prognosis; Random Allocation; Rats | 1991 |